SWOG Cancer Research Network: Urinary Bladder Neoplasms trials

The registry lists 14 Urinary Bladder Neoplasms studies with SWOG Cancer Research Network as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 9Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)TerminatedNCT04871529Phase 2Results posted
• Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by SurgeryActive, not recruitingNCT03757949Phase 3Results posted
• S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerCompletedNCT02177695Phase 2Results posted
• S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder CancerCompletedNCT01224665Not applicableResults posted
• S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerCompletedNCT00445601Phase 3Results posted
• S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-GuerinCompletedNCT00234039Phase 2Results posted
• S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumCompletedNCT00045630Phase 2Results posted
• S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractTerminatedNCT00022633Phase 2Results posted
• 4B951, Combination Chemotherapy in Treating Patients With Bladder CancerTerminatedNCT00005047Phase 3Results posted
• S0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumTerminatedNCT00087295Phase 2
• S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyCompletedNCT00066612Phase 2
• S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
• S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00014144Phase 2
• S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder CancerTerminatedNCT00003824Phase 3